Care and treatment

Resource
June 1, 2016

Worldwide, approximately 35 million individuals are infected with HIV; about 25 million of these live in sub-Saharan Africa. WHO proposes using treatment as prevention (TasP) to eliminate HIV. Treatment suppresses viral load, decreasing the probability an individual transmits HIV.

Resource
June 1, 2016

A qualitative study of women in Malawi who chose not to take HIV treatment as part of the country’s Option B+ programme, or who interrupted their treatment, has found that needing more time to think, concerns about partner support, and side-effects were important reasons for declining to take HIV

Resource
June 1, 2016

Treatment with efavirenz has been associated with rare but severe liver complications among patients receiving antiretroviral therapy (ART) in South Africa.

Resource
June 1, 2016

A cross-sectional survey of viral load in patients attending the largest clinic providing antiretroviral therapy (ART) in Kenya has shown that after an average of nearly two years on first-line, tenofovir-based ART, 76% maintained a viral load under 40 copies/ml and 85% under 1000 copies/ml, the

Resource
May 31, 2016

High rates of patient attrition from care between HIV testing and antiretroviral therapy (ART) initiation have been documented in sub-Saharan Africa, contributing to persistently low CD4 cell counts at treatment initiation.

Resource
May 31, 2016

We aimed to estimate the individual and joint impact of age, marital status and diagnosis with sexually transmitted infections (STIs) on HIV acquisition among young women at a population level in Durban, KwaZulu-Natal, South Africa.

Resource
May 16, 2016

This brief is part of a series on TB key populations launched by the Stop TB Partnership in May 2016.

Resource
May 16, 2016

This brief is part of a series on TB key populations launched by the Stop TB Partnership in May 2016.

Resource
May 16, 2016

This brief is part of a series on TB key populations launched by the Stop TB Partnership in May 2016.